TY - JOUR
T1 - Community acceptance of reactive focal mass drug administration and reactive focal vector control using indoor residual spraying, a mixed‐methods study in Zambezi region, Namibia
AU - Roberts, Kathryn W.
AU - Smith Gueye, Cara
AU - Baltzell, Kimberly
AU - Ntuku, Henry
AU - McCreesh, Patrick
AU - Maglior, Alysse
AU - Whittemore, Brooke
AU - Uusiku, Petrina
AU - Mumbengegwi, Davis
AU - Kleinschmidt, Immo
AU - Gosling, Roly
AU - Hsiang, Michelle S.
N1 - Funding Information:
The funding was provided by the Novartis Foundation, the Bill & Melinda Gates Foundation, and the Horchow Family Fund Scholarship at UT Southwestern. These funders were not involved in the study design, collection, analysis, or interpretation of the data, nor the drafting of this article.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Background: In Namibia, as in many malaria elimination settings, reactive case detection (RACD), or malaria testing and treatment around index cases, is a standard intervention. Reactive focal mass drug administration (rfMDA), or treatment without testing, and reactive focal vector control (RAVC) in the form of indoor residual spraying, are alternative or adjunctive interventions, but there are limited data regarding their community acceptability. Methods: A parent trial aimed to compare the effectiveness of rfMDA versus RACD, RAVC versus no RAVC, and rfMDA + RAVC versus RACD only. To assess acceptability of these interventions, a mixed-methods study was conducted using key informant interviews (KIIs) and focus group discussions (FGDs) in three rounds (pre-trial and in years 1 and 2 of the trial), and an endline survey. Results: In total, 17 KIIs, 49 FGDs were conducted with 449 people over three annual rounds of qualitative data collection. Pre-trial, community members more accurately predicted the level of community acceptability than key stakeholders. Throughout the trial, key participant motivators included: malaria risk perception, access to free community-based healthcare and IRS, and community education by respectful study teams. RACD or rfMDA were offered to 1372 and 8948 individuals in years 1 and 2, respectively, and refusal rates were low (< 2%). RAVC was offered to few households (n = 72) in year 1. In year 2, RAVC was offered to more households (n = 944) and refusals were < 1%. In the endline survey, 94.3% of 2147 respondents said they would participate in the same intervention again. Conclusions: Communities found both reactive focal interventions and their combination highly acceptable. Engaging communities and centering and incorporating their perspectives and experiences during design, implementation, and evaluation of this community-based intervention was critical for optimizing study engagement.
AB - Background: In Namibia, as in many malaria elimination settings, reactive case detection (RACD), or malaria testing and treatment around index cases, is a standard intervention. Reactive focal mass drug administration (rfMDA), or treatment without testing, and reactive focal vector control (RAVC) in the form of indoor residual spraying, are alternative or adjunctive interventions, but there are limited data regarding their community acceptability. Methods: A parent trial aimed to compare the effectiveness of rfMDA versus RACD, RAVC versus no RAVC, and rfMDA + RAVC versus RACD only. To assess acceptability of these interventions, a mixed-methods study was conducted using key informant interviews (KIIs) and focus group discussions (FGDs) in three rounds (pre-trial and in years 1 and 2 of the trial), and an endline survey. Results: In total, 17 KIIs, 49 FGDs were conducted with 449 people over three annual rounds of qualitative data collection. Pre-trial, community members more accurately predicted the level of community acceptability than key stakeholders. Throughout the trial, key participant motivators included: malaria risk perception, access to free community-based healthcare and IRS, and community education by respectful study teams. RACD or rfMDA were offered to 1372 and 8948 individuals in years 1 and 2, respectively, and refusal rates were low (< 2%). RAVC was offered to few households (n = 72) in year 1. In year 2, RAVC was offered to more households (n = 944) and refusals were < 1%. In the endline survey, 94.3% of 2147 respondents said they would participate in the same intervention again. Conclusions: Communities found both reactive focal interventions and their combination highly acceptable. Engaging communities and centering and incorporating their perspectives and experiences during design, implementation, and evaluation of this community-based intervention was critical for optimizing study engagement.
KW - Community acceptability
KW - Indoor residual spraying
KW - Malaria
KW - Malaria elimination
KW - Mass drug administration
KW - Namibia
KW - Plasmodium falciparum
KW - Qualitative and Mixed Methods
KW - Reactive case detection
UR - http://www.scopus.com/inward/record.url?scp=85103102969&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103102969&partnerID=8YFLogxK
U2 - 10.1186/s12936-021-03679-1
DO - 10.1186/s12936-021-03679-1
M3 - Article
C2 - 33752673
AN - SCOPUS:85103102969
SN - 1475-2875
VL - 20
JO - Malaria Journal
JF - Malaria Journal
IS - 1
M1 - 162
ER -